US Patent 7291331 Methods of treating OX40 medicated recall immune responses
Patent 7291331 was granted and assigned to La Jolla Institute for Allergy and Immunology on November, 2007 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7291331 Methods of treating OX40 medicated recall immune responses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
